<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-QSB
(Mark One)
[X] Quarterly report under Section 13 or 15(d) of the Securities
Exchange Act of 1934 For the quarterly period ended June 30, 2000
[ ] Transition report under Section 13 or 15(d) of the Exchange Act
For the transition period from _________ to __________
Commission file number 0-27889
EYE CARE INTERNATIONAL, INC.
----------------------------
Delaware 59-3206480
-------- ----------
(State or Other Jurisdiction of (IRS Employer
Incorporation or Organization) Identification No.)
1511 North Westshore Boulevard, Suite 925
Tampa , Florida 33607
----------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
(813) 289-5552
--------------
(Issuer's Telephone Number Including Area Code)
Check whether the issuer: (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports, and (2) has been
subject to such filing requirements for the past 90 days. Yes [X] No [ ]
APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS
Check whether the registrant filed all documents and reports required to be
filed by Section 12, 13 or 15(d) of the Exchange Act after the distribution of
securities under a plan confirmed by a court. Yes [ ] No [ ]
APPLICABLE ONLY TO CORPORATE ISSUERS
As of August 14, 2000, the issuer had 10,280,304 shares of common stock, $.001
par value, outstanding.
<PAGE> 2
EYE CARE INTERNATIONAL, INC.
Index
Part I. Financial Information
Item 1. Consolidated Financial Statements (Unaudited)
Consolidated Balance Sheet - June 30, 2000
Consolidated Statements of Income
Three Months Ended June 30, 2000 and 1999, and
Year to Date June 30, 2000 and 1999
Consolidated Statements of Cash Flows - Three Months Ended -
June 30, 2000 and 1999, and Year to Date June 30, 2000 and 1999
Consolidated Statement of Changes in Stockholders' Equity
Notes to Consolidated Financial Statements - June 30, 2000
Item 2. Management's Discussion and Analysis or Plan of Operation
Part II. Other Information
Item 2. Changes in Securities
Item 6. Exhibits and Reports on Form 8-K
Signatures
<PAGE> 3
PART I FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
In the opinion of management, the unaudited financial statement include all
adjustments necessary to present fairly the results for the three months ended
June 30, 2000, and year to date June 30, 2000.
The accompanying unaudited consolidated financial statements have been prepared
in accordance with generally accepted accounted principles for interim
financial information and with the instructions to Form 10-QSB. Accordingly,
they do not include all of the information and footnotes required by generally
accepted accounting principles for complete financial statements. In the
opinion of management, all adjustments (consisting of normal recurring
adjustments) considered necessary for a fair presentation have been included.
Operating results for the three months and six months ended June 30, 2000 are
not necessarily indicative of the results that may be expected for the year
ended December 31, 2000. For further information, refer to the consolidated
financial statements and footnotes thereto included in Eye Care International,
Inc.'s annual report on Form 10KSB for the year ended December 31, 1999.
<PAGE> 4
EYE CARE INTERNATIONAL, INC. AND SUBSIDIARY
CONSOLIDATED BALANCE SHEET
June 30, 2000
-------------
(Unaudited)
ASSETS
Current Assets
Cash $ 13,386
Accounts receivable $ 842,982
Miscellaneous receivables
and advances $ 245,967
-----------
$ 1,102,334
Fixed Assets - net of accumulated
depreciation $ 45,595
-----------
Total Assets $ 1,147,929
===========
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities
Accrued expenses and
taxes payable $ 761,070
Notes payable $ 50,000
-----------
$ 811,070
-----------
Stockholders' Equity
Capital stock
-30,000,000 shares of $.001 par value
common stock authorized; 9,990,304
issued at 6/30/00 $ 9,990
-10,000,000 shares of $.001 par value
preferred stock authorized:
745 Series A issued at 6/30/00 $ 1
685,714 Series B issued at 6/30/00 $ 686
Paid-in capital $ 7,391,904
Accumulated deficit $(7,065,722)
-----------
$ 336,859
-----------
Total liabilities and stockholders' equity $ 1,147,929
===========
The accompanying notes are an integral part of these financial statements.
<PAGE> 5
EYE CARE INTERNATIONAL, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF INCOME
<TABLE>
<CAPTION>
Year To Date June 30, Quarter Ended June 30,
----------------------------- -------------------------
2000 1999 2000 1999
----------- ----------- --------- ---------
(Unaudited)
<S> <C> <C> <C> <C>
Revenues
Memberships $ 980,399 $ 196,358 $ 86,850 $ 91,454
Interest $ 773 $ 6,648 $ 603 $ 5,047
----------- ----------- --------- ---------
$ 981,172 $ 203,006 $ 87,453 $ 96,501
General and administrative expenses $ 1,343,787 $ 1,041,113 $ 717,471 $ 446,705
Interest $ 2,000 $ 2,667 $ 1,000 $ 1,000
Depreciation $ 14,721 $ 16,080 $ 7,361 $ 8,003
----------- ----------- --------- ---------
$ 1,360,508 $ 1,059,860 $ 725,832 $ 455,708
Income/(loss) before cumulative effect of
accounting change $ ( 379,336) $ (856,854) $(638,379) $(359,207)
Cumulative effect of accounting change
to adopt SOP 98-5 $ 0 $ 749,433 $ 0 $ 0
Net income/(loss) $ (379,336) $(1,606,286) $(638,379) $(359,207)
Loss per Share $ (0.04) $ (0.19) $ (0.07) $ (0.04)
</TABLE>
The accompanying notes are an integral part of these financial statements.
<PAGE> 6
EYE CARE INTERNATIONAL, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS
<TABLE>
<CAPTION>
Year To Date June 30, Quarter Ended June 30,
2000 1999 2000 1999
--------- ----------- --------- ---------
<S> <C> <C> <C> <C>
Cash flow from operating activities
Net income/(loss) $(379,336) $(1,606,286) $(638,379) $(359,207)
Adjustment to reconcile net income
to net cash provided by operating
activities
Depreciation $ 14,721 $ 16,080 $ 7,361 $ 8,003
Accounting Change $ 0 $ 749,433 $ 0 $ 0
Changes in operating assets and liabilities
Decrease in accounts receivables $(768,064) $ 50,010 $ 20,736 $ 1,849
Increase in miscellaneous receivables $ (68,884) $ (95,606) $ (27,958) $ (41,502)
Increase/(Decrease) in accrued
expenses and taxes payable $ 308,092 $ 30,428 $ 205,237 $ 17,099
--------- ----------- --------- ---------
Net cash used by operating activities $(893,471) $ (855,941) $(433,003) $(373,758)
Cash flow from investing activities
Purchases of fixed assets $ 0 $ (2,472) $ 0 $ 0
Cash flows from financing activities
Proceeds from sale of common and
preferred stock $ 777,375 $ 406,500 $ 253,125 $ 160,500
--------- ----------- --------- ---------
Net cash provided by financing activities $ 777,375 $ 404,028 $ 253,125 $ 160,500
Increase/(Decrease) in cash $(116,096) $ (451,913) $(179,878) $(213,258)
Cash - beginning of period $ 129,482 $ 658,743 $ 193,264 $ 420,087
--------- ----------- --------- ---------
Cash - June 30, $ 13,386 $ 206,829 $ 13,386 $ 206,829
========= =========== ========= =========
Supplemental disclosures
Interest paid $ 0 $ 0 $ 0 $ 0
========= =========== ========= =========
Income taxes paid $ 0 $ 0 $ 0 $ 0
========= =========== ========= =========
</TABLE>
The accompanying notes are an integral part of these financial statements.
<PAGE> 7
EYE CARE INTERNATIONAL, INC.
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIENCY
<TABLE>
<CAPTION>
Common Preferred Paid-in Retained
Stock Stock Capital Deficit Total
----------- ----------- ---------- ----------- ------------
<S> <C> <C> <C> <C> <C>
Balance December 31, 1998 $ 8,504 $ 0 $5,722,202 $(3,990,800) $ 1,739,906
Net income/(loss) $(2,695,586) $(2,695,586)
Issuance of capital stock $ 506 $ 1 $ 893,993 $ 894,500
-----------
Balance December 31, 1999 $ 9,010 $ 1 $6,616,195 $(6,686,386) $ (61,180)
Net income/(loss) $ 259,043 $ 259,043
Issuance of capital stock $ 380 $ 523,870 $ 524,250
-----------
Balance March 31, 2000 $ 9,390 $ 1 $7,140,065 $(6,427,343) $ 722,113
Net income/(loss) $ (638,379) $ (638,379)
Issuance of capital stock $ 600 $ 686 $ 251,839 $ 253,125
-----------
Balance June 30, 2000 $ 9,990 $ 687 $7,391,904 $(7,065,722) $ 336,859
</TABLE>
The accompanying notes are an integral part of these financial statements.
<PAGE> 8
EYE CARE INTERNATIONAL, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2000
Note A - NATURE OF THE ORGANIZATION
Eye Care International, Inc. and Subsidiary ( the Company) markets
vision care benefit plans and enhancements to plans provided by others.
The Company's benefit plans and plan enhancements afford its member,
and those of its plan sponsors (employers, associations, etc.) and
other organizations, the opportunity to obtain discounted services from
its national network of ophthalmic physicians. Through contractual
arrangements with others, the Company's plan also provides its members
with access to providers of eyewear and other benefits on a discounted
basis.
Note B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
1. Principles of Consolidation
The consolidated financial statements include the accounts of the
Company intercompany transactions and balances have been eliminated in
consolidation.
2. Revenue Recognition
The Company sells one, two and three year memberships in its vision
plan. Upon receipt of the individual's enrollment form, the Company
issues a membership kit that includes a membership card, network
provider list and other materials which completes the Company's
obligation during the term of the membership. After thirty days, the
membership cannot be cancelled, therefore membership fees are
recognized in full at the time of enrollment. Cancellations generally
run less than one-half of one percent of gross sales. Membership fees,
however, cannot be determined nor estimated until reported to the
Company by the selling organization and are subject to possible
subsequent audit by the Company at its option under the terms of the
related agreement. Accordingly, depending upon the timeliness and
accuracy of membership reports received, membership income is not
recognized in the Company's financial statements until reported by the
selling organization. This has negligible effect, if any, on the
accuracy of the financial statements.
<PAGE> 9
EYE CARE INTERNATIONAL, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2000
Note B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
3. Fixed Assets and Depreciation
Fixed assets are recorded at cost. Depreciation of fixed assets is
recorded using accelerated and straight line methods over the estimated
useful lives of the related assets.
4. Income Taxes
Income taxes are to be provided for the tax effects of transactions
reported in the financial statements. Provisions will be made for
deferred income taxes, which result from timing differences between
expenses and income as reported for financial statement purposes and
their deductibility or exclusion for income tax purposes, when
appropriate.
5. Warrants
The Company has issued 1,682,500 warrants for the purchase of common
stock. Of these warrants, 82,500 have an exercise price of $1.00 per
share and expire at various dates from January 1, 2001 to April 2003.
These warrants were issued to individuals who made loans to the Company
in 1995 through 1997 at the rate of one warrant per dollar loaned. Upon
maturity, $32,500 of the notes were paid in full without the holder
exercising the warrants. The remaining 50,000 warrants relate to the
notes payable detailed in Note C.
An additional 400,000 warrants were issued in 1998 to an individual as
an incentive to sign a "spokesperson" contract for future service.
These warrants have an exercise price of $1.50 per share and expire in
June 2003. In June 2000, the Company issues 1,200,000 warrants to
individuals purchasing Preferred Stock from the Company. These warrants
are exercisable at the price of $0.50 per share of common stock and
expire in June 2005.
6. Preferred Stock
In late 1999 the Company issued 495 shares of Series A convertible
preferred stock at a price of $1,000 per share. Each share of preferred
stock is convertible into 2,000 shares of common stock and has a
liquidation preference of $1,000 per share. The Company has the right
to redeem shares of Series A convertible preferred stock on the third
anniversary of the date shares of said stock were first issued at a
redemption price of $1,200 per share.
<PAGE> 10
EYE CARE INTERNATIONAL, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2000
Note B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
In May 2000, the Company issued 685,714 shares of Series B convertible
preferred stock at a price of $0.4375 per share. Each preferred share
is convertible into one share of common stock. This stock has no
liquidation preference nor redemption features.
7. Change in Accounting Principle
Effective January 1, 1999, the Company adopted Statement of Position
98-5, Reporting on the Costs of Start-up Activities. This statement
requires that certain costs of start-up activities and organization
costs be expensed as incurred rather than capitalized and amortized
under previous accounting principles. The cumulative effect of the
change on net income was $749,433.
8. Diluted Earnings/(Loss) Per Share
Since the Company has shown a loss during each of the periods
presented, no diluted loss per share calculations have been presented.
Showing the affect of including the outstanding warrants in the
earnings/(loss) per share calculation would have an anti-dilution
effect.
Note C - NOTES PAYABLE
The Company is indebted to two stockholders in the amount of $25,000
each. These monies bear interest at the rate of 8% and are payable upon
demand.
Note D - INCOME TAXES
Substantially all of the Company's retained earnings deficit will be
available as an operating loss carryforward to reduce future income tax
obligations as may be incurred through the year 2015. However, because
of the Company's relative short operating history, the potential tax
benefit of this loss has been valued at zero in the financial
statements and will remain so until realized or until the criterion in
Financial Accounting Standards Board Statement No. 109, Accounting for
Income Taxes, for recognition of a deferred tax asset has been met.
<PAGE> 11
EYE CARE INTERNATIONAL, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2000
Note E - COMMITMENTS AND CONTINGENCIES
The Company leases its present offices under an operating lease
expiring on July 31, 2003 with an option to renew for one year. Rent
expense for the years 1999 and 1998 amounted to $87,576 and $54,416,
respectively. Future minimum rental commitments, at December 31, 1999
are as follows:
2000 $ 92,408
2001 $ 96,523
2002 $100,992
2003 $ 42,855
--------
$419,994
========
Note F - GOING CONCERN
The accompanying financial statements have been prepared in conformity
with generally accepted accounting principles, which contemplates
continuation of the Company as a going concern. However, the Company
has sustained substantial operating losses since its inception. In
addition, the Company has used substantial amounts of working capital
in its operations. In view of these matters, the continuation of the
Company is dependent upon its ability to raise capital and its success
of future operations. Absent an increase in revenue or the sale of
capital stock, there may be uncertainty about the Company's ability to
continue as a going concern. Management believes that the Company will
generate significant new business in the future and will also be able
to sell shares of its capital stock to continue as a going concern. The
financial statements do not include any adjustments that might result
from the outcome of this uncertainty.
<PAGE> 12
EYE CARE INTERNATIONAL, INC.
MANAGEMENT'S DISCUSSIONS AND ANALYSIS
OR PLAN OF OPERATION
Item 2. Management's Discussion and Analysis or Plan of Operation.
The following discussion and analysis of our financial condition and
results of operation should be read in conjunction with the financial statements
and notes thereto appearing elsewhere in this report.
RESULTS OF OPERATIONS
THREE MONTHS ENDED JUNE 30, 2000
SALES. Sales for the three months ended June 30, 2000, of $86,850 were $4,604
lower than the $91,454 recorded during the same period in 1999. This decrease
was primarily due to the timing of customer renewals.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES. The major components of Selling,
General & Administrative expenses (G&A) are Payroll, Commissions, Business
Travel, Postage & Printing, and Profession/Consulting Fees. G&A expenses of
$717,471 were approximately $271,000, higher than the $446,705 for the quarter
ended June 30, 1999. The increase in G&A expenses was primarily due to a $71,000
increase in payroll, a $30,000 increase in postage and printing, a $56,000
increase in professional/consulting fees and a $71,000 increase in contract
labor.
Payroll increased to $287,414 from $215,998 in the same period of 1999 because
of the addition of three regional account executives, payroll increases and the
increased cost of benefits due to rate increases and the increased number of
employees covered.
Postage and Printing increased from $30,331 in the second quarter of 1999 to
$60,469 in the second quarter of 2000 because of costs incurred in printing and
filing Securities and Exchange documents and costs associated with the printing
and publishing newspaper articles.
Consulting/Professional expenses increased to $93,463 from $37,477 in the same
quarter of 1999 primarily because of increased legal fees associated with the
filing of Securities and Exchange documents and the fees incurred in determining
the licensing requirements, if any, in certain states, as well as other
increased legal activities.
Contract labor increased approximately $71,000 to $71,343 in the second quarter
2000 as the Company elected to utilize temporary /placement agency employees in
lieu of immediately hiring additional employees and the use of a celebrity to
help market the Company's plan.
<PAGE> 13
INTEREST INCOME. Interest income for the second quarter of 2000 of $603 was
about $4,500 lower than the interest earned during the same period in 1999. The
Company maintained a cash balance significantly higher in the second quarter of
1999 than in the current year's quarter and was thus able to invest more
principal in interest bearing securities.
INTEREST EXPENSE. Interest expense of $1,000 was the same as in the quarter
ended June 30, 1999.
DEPRECIATION AND AMORTIZATION EXPENSE. Since no major depreciable assets were
added during 1999 or the first six months of 2000, depreciation expense of
$7,361 was about $600 less than the second quarter of 1999.
RESULTS OF OPERATIONS
SIX MONTHS ENDED JUNE 30, 2000
SALES. Sales for the six months ended June 30, 2000, of $980,399 were
approximately $784,000 higher than the $197,800 recorded during the same period
in 1999. This increase was primarily due to a receivable of approximately
$761,000 being recorded in the first quarter of 2000 and billed to a private
label marketer for sales which the Company believes the marketer failed to
report. This bill is being disputed by the marketer, who claims no additional
liability exists other than those previously reported by the marketer. The
Company anticipates a resolution will be secured before the end of the year.
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES. The major components of Selling,
General & Administrative expenses (G&A) are Payroll, Commissions, Business
Travel, Postage & Printing, and Profession/Consulting Fees. G&A expenses of
$1,343,787 were approximately $303,000, higher than the $1,041,113 for the six
months ended June 30, 1999.
The increase in G&A expenses was primarily due to a $55,000 increase in payroll,
a $23,000 increase in postage and printing, a $93,000 increase in
professional/consulting fees, a $93,000 increase in contract labor, and a
$23,000 increase in travel expenses.
Payroll increased to $530,732 from $475,189 in the same period of 1999 because
of the addition of three regional account executives, payroll increases and the
increased cost of benefits due to rate increases and the increased number of
employees covered.
Postage and Printing increased from $82,422 in the first six months of 1999 to
$105,218 for the same period in 2000 because of costs incurred in printing and
filing Securities and
<PAGE> 14
Exchange documents, and costs associated with the printing and publishing of
newspaper articles.
Consulting/Professional expenses increased to $187,312 from $94,319 in the first
six months 1999 primarily because of increased legal fees associated with the
filing of Securities and Exchange documents, legal fees incurred in determining
the licensing requirements, if any, in certain states, consulting fees paid for
corporate communications services, as well as other increased legal activities.
Contract labor increased approximately $93,000 to $93,690 for the first six
months of 2000 as the Company elected to utilize temporary and placement agency
employees in lieu of immediately hiring additional employees and the use of a
celebrity to help market the Company's plan.
INTEREST INCOME. Interest income for the first six months of 2000 of $713 was
about $4,200 lower than the interest earned during the same period in 1999. The
Company maintained a cash balance significantly higher in the first half of 1999
than in the first half of 2000 and was thus able to invest more principal in
interest bearing securities.
INTEREST EXPENSE. Interest expense of $2,000 was approximately $700 less than
the $2,667 recorded during the first six months of 1999.
DEPRECIATION AND AMORTIZATION EXPENSE. Since no major depreciable assets were
added during 1999 or the first six months of 2000, depreciation expense of
$14,721 was about $600 less than the same period of 1999.
CHANGE IN ACCOUNTING PRINCIPLE. Effective January 1, 1999, the Company adopted
Statement of Position 98-5, "Reporting on the Costs of Start-up Activities",.
This statement requires that certain costs of start-up activities and
organization costs be expensed as incurred rather than capitalized and amortized
under previous accounting principles. The cumulative effect of the change on net
income was $749,433, net of taxes in the amount of $0, since the Company has
loss carryforwards.
LIQUIDITY AND CAPITAL RESOURCES
Since inception, the company's expenses has consistently exceeded its revenues.
Operations have primarily been funded from the issuance of debt and equity
securities aggregating approximately $7.8 million, which includes $50,000 in
notes payable.
The Company used cash in its operating activities totaling $.9 million and $.9
million during the first six months of 2000 and 1999. respectively, primarily
for payroll, professional/consulting fees, contract labor, and postage/printing.
The Company did not acquire any fixed assets during the six month period ended
June 30, 2000, but did invest $2,472 during the first half of 1999 to acquire
computers and office equipment.
<PAGE> 15
During the first six months of 2000 the Company raised $777,375 as compared to
$406,500 during the same period of 1999 through financing activities; primarily
the sale of convertible preferred stock in 2000 and the sale of common stock in
1999. In the first quarter of 2000, the Company issued 550 shares of Series A
convertible preferred stock at a price of $1,000 per share. Each share can be
converted into 2,000 shares of common stock.
The Company also sold 685,714 shares of Series B convertible preferred stock at
a price of $.4375 during the second quarter of 2000. Each of these shares can be
converted to one share of common stock.
GOING CONCERN.
Note F to the audited financials expresses the uncertainty of the Company's
ability to continue as a going concern. Management believes that significant
revenues will be generated in the near future as a result of marketing
arrangements entered into and /or under negotiations.
FORWARD-LOOKING STATEMENTS
This report includes forward-looking statements that are not based upon
historical facts. These statements, which discuss future expectations, estimate
the happening of future events, or our results of operations or financial
condition for future periods, can be identified by the use of forward-looking
terminology such as "may", "will", "expect", "believe", 'intend", "anticipate",
"estimate", "continue", or similar words. These forward-looking statements are
subject to certain uncertainties, and there are important factors that may
cause actual results to differ materially from those expressed or implied by
these forward-looking statements.
<PAGE> 16
PART II
Item 2. Changes in Securities
During the first quarter of 2000, the Company sold and aggregate of 550
shares of Series A convertible preferred stock to six accredited investors for a
total purchase price of $550,000 ($1,000 per share). Each share can be converted
into 2,000 shares of class A common stock.
During the quarter ended June 30, 2000 the Company sold an aggregate
685,714 shares of Series B Convertible Preferred Stock to three accredited
investors for a total purchase price of $300,000 ($.4375 per share). Each share
is convertible into one share of class A common stock.
These transactions were exempt from the registration requirements of
the Securities Act under Section 4 (2) of the Securities Act and Rule 506 of
Registration D. There were underwriters fees involved in these transactions, but
no underwriting discounts paid in connection with these transactions. The
purchasers in each transaction represented their intention to acquire the
securities for investment only and not with a view to or offer for sale in
connection with any distribution of the securities and appropriate legends were
affixed to the certificates for the securities issued in such transactions. All
purchasers of securities in these transactions had adequate access to
information about the Company and were sophisticated investors.
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits
27.1 -- Financial Data Schedule (for SEC use only)
(b) Reports on Form 8-K
None
<PAGE> 17
Signatures
In accordance with the requirements of the Exchange Act, the registrant has
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
EYE CARE INTERNATIONAL, INC.
Date: August 17, 2000 by: /s/ James L. Koenig
----------------------------------------
James L. Koenig, Chief Financial Officer
